“Reluctant activist” investor George Haywood has a new biotech target in his sights.
Sign Up For Our Free Newsletter
George Haywood has an unusual career and socially conscious approach to activism. After successfully brokering in the Sirius / XM satellite deal, where he sat on the board for a time, and engaging in activist maneuvers with Sarepta Therapeutics Inc (NASDAQ:SRPT), investing when the biotech firm had a mere $150 million valuation and watching it grow to over $1 billion in value as it helps solve a key medical problem, the investor now has his sights on krill oil.
Neptune Technologies, George Haywood's latest activist target
George Haywood’s latest activist target is Neptune Technologies & Bioressources (NASDAQ:NEPT), he revealed in...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
